7Baggers

Takeda Pharmaceutical Company Limited
(NYSE:TAK) 

TAK stock logo

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncolog...

Founded: 1781
Full Time Employees: 47,495
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-10-30 2025-07-30 2025-05-08 2025-03-31 2025-01-30 2024-10-31 2024-07-31 2024-05-09 2024-03-31 2024-02-02 2024-02-01 2023-10-30 2023-10-26 2023-08-01 2023-07-27 2023-05-11 2023-03-31 2023-02-07 2023-02-02 2022-11-04 2022-10-27 2022-08-04 2022-07-28 2022-05-11 2022-03-31 2022-02-10 2022-02-03 2021-11-05 2021-10-28 2021-08-06 2021-07-30 2021-05-11 2021-03-31 2021-02-12 2021-02-04 2020-11-30 2020-11-10 2020-10-29 2020-08-12 2020-07-31 2020-06-24 2020-05-13 2020-03-31 2020-02-13 2020-02-04 2019-11-29 2019-11-12 2019-10-31 2019-08-09 2019-07-31 2019-05-30 2019-05-14 2019-03-31 2019-02-15 2019-02-14 2019-02-01 
                                                            
      revenue
    		2,219,481,000,000 1,106,685,000,000 4,581,551,000,000  3,528,152,000,000 2,384,028,000,000 1,207,990,000,000 4,263,762,000,000  3,212,893,000,000 3,212,893,000,000 2,101,707,000,000 2,101,707,000,000 1,058,618,000,000 1,058,618,000,000 4,027,478,000,000  2,695,717,000,000 3,071,322,000,000 1,794,423,000,000 1,974,771,000,000 949,603,000,000 972,465,000,000 3,569,006,000,000  2,427,538,000,000 2,695,717,000,000 1,590,785,000,000 1,590,785,000,000 801,850,000,000 949,603,000,000 3,197,812,000,000  2,519,486,000,000 2,427,538,000,000  1,660,169,000,000 1,590,785,000,000 801,850,000,000 801,850,000,000  3,291.2  2,519,486,000,000 2,519,486,000,000 1,660,169,000,000 1,660,169,000,000 1,660,169,000,000 849,121,000,000 849,121,000,000 1,732,100 2,097,224,000,000   1,380,013,000,000 1,380,013,000,000 
      yoy
    		-37.09% -53.58% 279.27%   -25.80% -62.40% 102.87%  203.50% 203.50% -47.82%  -60.73% -65.53% 124.44%  183.88% 215.83% -49.72%  -60.88% -63.93% 124.36%  202.74% 183.88% -50.25%  -68.17% -60.88%   58.38% 202.74%   48334497955.42%  -68.17%  -100.00%  51.76% 196.72% 95.52% 95847079.72% -20.84%   -100.00% 51.97%     
      qoq
    		100.55% -75.84%   47.99% 97.35% -71.67%   0.00% 52.87% 0.00% 98.53% 0.00% -73.72%   -12.23% 71.16% -9.13% 107.96% -2.35% -72.75%   -9.95% 69.46% 0.00% 98.39% -15.56% -70.30%   3.79%   4.36% 98.39% 0.00%     0.00% 51.76% 0.00% 0.00% 95.52% 0.00% 49022531.49% -100.00%    0.00%  
      cost of sales
    		-764,736,000,000 -384,675,000,000 -1,580,217,000,000  -1,198,139,000,000 -781,265,000,000 -386,954,000,000 -1,426,678,000,000  -1,044,177,000,000 -1,044,177,000,000 -664,696,000,000 -664,696,000,000 -321,114,000,000 -321,114,000,000 -1,244,072,000,000  -798,466,000,000 -934,300,000,000 -517,061,000,000 -598,327,000,000 -241,264,000,000 -292,882,000,000 -1,106,846,000,000  -740,862,000,000 -798,466,000,000 -487,720,000,000 -487,720,000,000 -238,078,000,000 -241,264,000,000 -994,308,000,000  -841,583,000,000 -740,862,000,000  -562,008,000,000 -487,720,000,000 -238,078,000,000 -238,078,000,000 4,739,200,000 -1,089.8  -841,583,000,000 -841,583,000,000 -572,302,000,000 -572,302,000,000 -572,302,000,000 -300,592,000,000 -300,592,000,000 -253,000 -659,690,000,000  4,739,200,000 -369,855,000,000 -369,855,000,000 
      selling, general and administrative expenses
    		-509,436,000,000 -255,885,000,000 -1,104,766,000,000  -808,900,000,000 -538,312,000,000 -270,030,000,000 -1,053,819,000,000  -768,585,000,000 -768,585,000,000 -501,065,000,000 -501,065,000,000 -248,113,000,000 -248,113,000,000 -997,309,000,000  -662,932,000,000 -742,513,000,000 -431,854,000,000 -480,214,000,000 -219,843,000,000 -231,480,000,000 -886,361,000,000  -641,275,000,000 -662,932,000,000 -418,631,000,000 -418,631,000,000 -202,374,000,000 -219,843,000,000 -875,663,000,000  -711,679,000,000 -641,275,000,000  -462,469,000,000 -418,631,000,000 -202,374,000,000 -202,374,000,000  -964.7  -711,679,000,000 -711,679,000,000 -462,469,000,000 -462,469,000,000 -462,469,000,000 -239,213,000,000 -239,213,000,000  -717,599,000,000   -447,677,000,000 -447,677,000,000 
      research and development expenses
    		-305,373,000,000 -143,891,000,000 -730,227,000,000  -514,220,000,000 -344,027,000,000 -168,463,000,000 -729,924,000,000  -534,068,000,000 -534,068,000,000 -346,687,000,000 -346,687,000,000 -162,741,000,000 -162,741,000,000 -633,325,000,000  -382,459,000,000 -472,381,000,000 -254,081,000,000 -297,752,000,000 -122,480,000,000 -143,607,000,000 -526,087,000,000  -342,544,000,000 -382,459,000,000 -224,978,000,000 -224,978,000,000 -106,821,000,000 -122,480,000,000 -455,833,000,000  -353,072,000,000 -342,544,000,000  -230,363,000,000 -224,978,000,000 -106,821,000,000 -106,821,000,000  -492.4  -353,072,000,000 -353,072,000,000 -230,363,000,000 -230,363,000,000 -230,363,000,000 -116,866,000,000 -116,866,000,000  -368,298,000,000   -228,893,000,000 -228,893,000,000 
      amortization and impairment losses on intangible assets associated with products
    		-336,793,000,000 -131,638,000,000 -643,233,000,000  -440,158,000,000 -305,245,000,000 -162,831,000,000 -652,117,000,000  -507,003,000,000 -507,003,000,000 -369,665,000,000 -369,665,000,000 -129,423,000,000 -129,423,000,000 -542,443,000,000  -323,632,000,000 -409,219,000,000 -205,545,000,000 -273,643,000,000 -102,824,000,000 -131,277,000,000 -472,915,000,000  -307,570,000,000 -323,632,000,000 -208,097,000,000 -208,097,000,000 -104,250,000,000 -102,824,000,000 -421,864,000,000  -329,148,000,000 -307,570,000,000  -225,223,000,000 -208,097,000,000 -104,250,000,000 -104,250,000,000    -329,148,000,000 -329,148,000,000 -273,652,000,000 -273,652,000,000 -273,652,000,000 -148,258,000,000 -148,258,000,000  -203,372,000,000   -79,390,000,000 -79,390,000,000 
      other operating income
    		23,519,000,000 22,030,000,000 26,212,000,000  16,227,000,000 13,933,000,000 10,868,000,000 19,379,000,000  10,768,000,000 10,768,000,000 9,874,000,000 9,874,000,000 4,251,000,000 4,251,000,000 25,424,000,000  34,269,000,000 16,676,000,000 19,535,000,000 13,476,000,000 11,118,000,000 5,479,000,000 43,123,000,000  118,532,000,000 34,269,000,000 69,463,000,000 69,463,000,000 63,732,000,000 11,118,000,000 318,020,000,000  29,794,000,000 118,532,000,000  11,316,000,000 69,463,000,000 63,732,000,000 63,732,000,000  60.2  29,794,000,000 29,794,000,000 11,316,000,000 11,316,000,000 11,316,000,000 6,666,000,000 6,666,000,000  159,863,000,000   61,667,000,000 61,667,000,000 
      other operating expenses
    		-73,101,000,000 -28,061,000,000 -206,733,000,000  -165,444,000,000 -78,537,000,000 -64,252,000,000 -206,527,000,000  -145,685,000,000 -145,685,000,000 -110,240,000,000 -110,240,000,000 -32,907,000,000 -32,907,000,000 -145,247,000,000  -100,034,000,000 -127,643,000,000 -59,438,000,000 -83,359,000,000 -25,758,000,000 -28,182,000,000 -159,075,000,000  -155,090,000,000 -100,034,000,000 -105,234,000,000 -105,234,000,000 -46,774,000,000 -25,758,000,000 -258,895,000,000  -151,254,000,000 -155,090,000,000  -82,389,000,000 -105,234,000,000 -46,774,000,000 -46,774,000,000  -248.7  -151,254,000,000 -151,254,000,000 -82,389,000,000 -82,389,000,000 -82,389,000,000 -40,992,000,000 -40,992,000,000 -154,000 -103,159,000,000   -31,445,000,000 -31,445,000,000 
      operating profit
    		253,561,000,000 184,566,000,000 342,586,000,000  417,518,000,000 350,576,000,000 166,329,000,000 214,075,000,000  224,144,000,000 224,144,000,000 119,230,000,000 119,230,000,000 168,571,000,000 168,571,000,000 490,505,000,000  462,463,000,000 401,943,000,000 345,979,000,000 254,953,000,000 248,552,000,000 150,515,000,000 460,844,000,000  358,729,000,000 462,463,000,000 215,588,000,000 215,588,000,000 167,285,000,000 248,552,000,000 509,269,000,000  162,544,000,000 358,729,000,000  109,033,000,000 215,588,000,000 167,285,000,000 167,285,000,000  100.4  162,544,000,000 162,544,000,000 50,310,000,000 50,310,000,000 50,310,000,000 9,866,000,000 9,866,000,000 155,900 204,969,000,000   284,420,000,000 284,420,000,000 
      yoy
    		-39.27% -47.35% 105.97%   56.41% -25.79% 79.55%  32.97% 32.97% -75.69%  -63.55% -58.06% 41.77%  86.06% 167.05% -24.92%  -30.71% -67.45% 113.76%  114.44% 86.06% -57.67%  2.92% -30.71%   -24.60% 114.44%   214729083565.34%  2.92%  -100.00%  223.08% 1547.52% 409.93% 32270586.34% -75.45%   -100.00% -27.93%     
      qoq
    		37.38% -46.13%   19.09% 110.77% -22.30%   0.00% 87.99% 0.00% -29.27% 0.00% -65.63%   15.06% 16.18% 35.70% 2.58% 65.13% -67.34%   -22.43% 114.51% 0.00% 28.87% -32.70% -51.19%   -54.69%   -49.43% 28.87% 0.00%     0.00% 223.08% 0.00% 0.00% 409.93% 0.00% 6328315.65% -100.00%    0.00%  
      operating margin %
    		11.42% 16.68% 7.48% NaN% 11.83% 14.71% 13.77% 5.02% NaN% 6.98% 6.98% 5.67% 5.67% 15.92% 15.92% 12.18% NaN% 17.16% 13.09% 19.28% 12.91% 26.17% 15.48% 12.91% NaN% 14.78% 17.16% 13.55% 13.55% 20.86% 26.17% 15.93% NaN% 6.45% 14.78% NaN% 6.57% 13.55% 20.86% 20.86% NaN% 3.05% NaN% 6.45% 6.45% 3.03% 3.03% 3.03% 1.16% 1.16% 9.00% 9.77% NaN% NaN% 20.61% 20.61% 
      finance income
    		118,154,000,000 73,758,000,000 46,549,000,000  27,805,000,000 34,793,000,000 30,677,000,000 52,093,000,000  46,101,000,000 46,101,000,000 24,312,000,000 24,312,000,000 26,455,000,000 26,455,000,000 62,913,000,000  42,949,000,000 55,130,000,000 46,912,000,000 75,707,000,000 45,851,000,000 60,925,000,000 23,700,000,000  58,030,000,000 42,949,000,000 29,628,000,000 29,628,000,000 19,611,000,000 45,851,000,000 105,521,000,000  32,517,000,000 58,030,000,000  17,370,000,000 29,628,000,000 19,611,000,000 19,611,000,000  27.8  32,517,000,000 32,517,000,000 17,370,000,000 17,370,000,000 17,370,000,000 8,668,000,000 8,668,000,000  16,843,000,000   9,437,000,000 9,437,000,000 
      finance expenses
    		-190,296,000,000 -107,158,000,000 -210,065,000,000  -159,741,000,000 -128,145,000,000 -59,691,000,000 -219,850,000,000  -172,663,000,000 -172,663,000,000 -106,095,000,000 -106,095,000,000 -59,575,000,000 -59,575,000,000 -169,698,000,000  -143,539,000,000 -126,765,000,000 -104,940,000,000 -109,272,000,000 -71,068,000,000 -55,469,000,000 -166,607,000,000  -173,389,000,000 -143,539,000,000 -110,720,000,000 -110,720,000,000 -46,846,000,000 -71,068,000,000 -248,631,000,000  -123,955,000,000 -173,389,000,000  -99,268,000,000 -110,720,000,000 -46,846,000,000 -46,846,000,000  -165  -123,955,000,000 -123,955,000,000 -99,268,000,000 -99,268,000,000 -99,268,000,000 -46,064,000,000 -46,064,000,000  -83,289,000,000   -41,518,000,000 -41,518,000,000 
      share of loss of investments accounted for using the equity method
    		-2,615,000,000 -536,000,000     -712,000,000       -418,000,000 -418,000,000 -8,630,000,000  -5,255,000,000 -3,133,000,000 -3,525,000,000 -1,366,000,000 -357,000,000 -497,000,000    -5,255,000,000  -8,935,000,000 -9,759,000,000 -357,000,000    -8,013,000,000         -15,098,000,000 -15,098,000,000          -43,960,000,000  
      profit before tax
    		178,804,000,000 150,630,000,000 175,084,000,000  282,383,000,000 255,976,000,000 136,604,000,000 52,791,000,000  100,313,000,000 100,313,000,000 39,053,000,000 39,053,000,000 135,033,000,000 135,033,000,000 375,090,000,000  356,618,000,000 327,175,000,000 284,425,000,000 220,022,000,000 222,978,000,000 155,473,000,000 302,571,000,000  235,357,000,000 356,618,000,000 125,561,000,000 125,561,000,000 130,291,000,000 222,978,000,000 366,235,000,000  56,008,000,000 235,357,000,000  31,166,000,000 125,561,000,000 130,291,000,000 130,291,000,000  -60.8  56,008,000,000 56,008,000,000 -27,557,000,000 -27,557,000,000 -27,557,000,000 -25,186,000,000 -25,186,000,000  94,896,000,000   208,379,000,000 208,379,000,000 
      income tax expenses
    		-66,254,000,000 -26,351,000,000     -41,304,000,000       -45,627,000,000 -45,627,000,000 -58,052,000,000   -41,273,000,000 -100,704,000,000 -53,269,000,000 -85,252,000,000 -50,452,000,000   -56,330,000,000 -115,077,000,000  -38,972,000,000 -47,772,000,000 -22,558,000,000   -13,280,000,000 -56,330,000,000    -47,772,000,000 -47,772,000,000    -13,280,000,000 -13,280,000,000       14,118,000,000   -44,026,000,000 -44,026,000,000 
      net profit for the period
    		112,550,000,000 124,279,000,000   211,241,000,000 187,406,000,000 95,299,000,000   147,191,000,000 147,191,000,000 41,436,000,000 41,436,000,000 89,406,000,000 89,406,000,000   241,541,000,000 285,903,000,000 183,721,000,000 166,753,000,000 137,726,000,000 105,021,000,000   179,027,000,000 241,541,000,000 86,589,000,000 86,589,000,000 82,519,000,000 200,421,000,000   42,728,000,000 179,027,000,000  74,834,000,000 86,589,000,000 82,519,000,000 82,519,000,000    42,728,000,000 42,728,000,000 33,280,000,000 33,280,000,000 33,280,000,000 -20,636,000,000 -20,636,000,000     164,353,000,000 164,353,000,000 
      attributable to:
    		                                                        
      owners of the company
    		112,441,000,000 124,243,000,000 107,928,000,000  211,083,000,000 187,294,000,000 95,248,000,000 144,067,000,000  147,085,000,000 147,085,000,000 41,365,000,000 41,365,000,000 89,395,000,000 89,395,000,000 317,017,000,000  241,417,000,000 285,883,000,000 183,648,000,000 166,756,000,000 137,684,000,000 105,014,000,000 230,059,000,000  178,907,000,000 241,417,000,000 86,548,000,000 86,548,000,000 82,511,000,000 200,378,000,000 376,005,000,000  42,517,000,000 178,907,000,000  74,738,000,000 86,548,000,000 82,511,000,000 82,511,000,000    42,517,000,000 42,517,000,000 33,184,000,000 33,184,000,000 33,184,000,000 -20,660,000,000 -20,660,000,000  109,126,000,000   164,434,000,000 164,434,000,000 
      non-controlling interests
    		108,000,000 36,000,000 215,000,000  158,000,000 112,000,000 51,000,000 130,000,000  106,000,000 106,000,000 71,000,000 71,000,000 11,000,000 11,000,000 21,000,000  124,000,000 19,000,000 73,000,000  43,000,000 7,000,000 107,000,000  120,000,000 124,000,000 41,000,000 41,000,000 8,000,000 43,000,000 166,000,000  211,000,000 120,000,000  96,000,000 41,000,000 8,000,000 8,000,000    211,000,000 211,000,000 96,000,000 96,000,000 96,000,000 24,000,000 24,000,000  -112,000,000   -81,000,000 -81,000,000 
      earnings per share
    		                                                        
      basic earnings per share
    		71.57 79.4 68.36  133.71 118.85 60.71 92.09  94.1 94.1 26.51 26.51 57.51 57.51 204.29  154.09 184.32 117.08 107.62 87.96 67.94 147.14  114.57 154.09 55.45 55.45 52.93 128.02 240.72  27.31 114.57  48.01 55.45 52.93 52.93    27.31 27.31 21.32 21.32 21.32 -13.28 -13.28 147.15 113.5   209.87 209.87 
      diluted earnings per share
    		70.45 78.23 67.23  131.69 117.11 59.94 91.16  93.17 93.17 26.29 26.29 57.12 57.12 201.94  153.03 182.65 116.4 106.88 87.45 67.56 145.87  113.72 153.03 55.13 55.13 52.69 127.27 238.96  27.19 113.72  47.87 55.13 52.69 52.69    27.19 27.19 21.25 21.25 21.25 -13.28 -13.28  112.86   208.64 208.64 
      share of profit of investments accounted for using the equity method
    		  -3,986,000,000  -3,199,000,000 -1,247,000,000  6,473,000,000  2,731,000,000 2,731,000,000 1,607,000,000 1,607,000,000           -15,367,000,000  -8,013,000,000  -8,935,000,000    76,000,000  -15,098,000,000   4,031,000,000 -8,935,000,000 -9,759,000,000 -9,759,000,000      4,031,000,000 4,031,000,000 4,031,000,000 2,344,000,000 2,344,000,000      -43,960,000,000 
      income tax (expenses) benefit
    		  -66,941,000,000  -71,142,000,000 -68,570,000,000  91,406,000,000  46,878,000,000 46,878,000,000 2,382,000,000 2,382,000,000     -115,077,000,000      -72,405,000,000    -38,972,000,000         43,668,000,000 -38,972,000,000        60,837,000,000 60,837,000,000 60,837,000,000 4,550,000,000 4,550,000,000       
      net profit for the year
    		  108,143,000,000     144,197,000,000        317,038,000,000        230,166,000,000        376,171,000,000          44.3         115,500 109,014,000,000     
      name of shareholders
    		                                                        
      takeda pharmaceutical company limited
    		                 1,000,000  1,000,000  1,000,000    1,000,000  1,000,000  1,000,000    1,000,000   1,000,000                    
      amato pharmaceutical products, ltd.
    		                 5,000,000  5,000,000  5,000,000    5,000,000  5,000,000  5,000,000    5,000,000   5,000,000                    
      watanabe chemical, co.,ltd.
    		                 6,000,000  6,000,000  6,000,000    6,000,000  6,000,000  6,000,000    6,000,000   6,000,000                    
      total
    		                 21,753,200,000,000  21,752,000,000,000  29,841,600,000,000    15,798,200,000,000  461,700,000,000  460,500,000,000    458,700,000,000   457,900,000,000                    
      note
    		                 2,021,000,000  2,021,000,000  2,021,000,000    2,020,000,000  2,020,000,000  2,020,000,000    2,019,000,000   2,019,000,000                    
      underlying revenue growth
    		                                                        
      underlying core operating profit growth
    		                                                        
      underlying core operating profit margin
    		                                                        
      underlying core eps growth
    		                                                        
      income tax benefit
    		                               9,936,000,000         -430,900,000 105            -430,900,000   
      revenues:
    		                                                        
      product sales
    		                                        15,017,200,000             15,017,200,000   
      royalties and other revenues
    		                                        472,800,000             472,800,000   
      total revenues
    		                                        15,490,000,000             15,490,000,000   
      costs and expenses:
    		                                                        
      research and development
    		                                        1,695,300,000             1,695,300,000   
      selling, general and administrative
    		                                        3,399,800,000             3,399,800,000   
      amortization of acquired intangible assets
    		                                        1,806,200,000             1,806,200,000   
      integration and acquisition costs
    		                                        585,100,000             585,100,000   
      reorganization costs
    		                                        286,200,000             286,200,000   
      gain on sale of oncology and product rights
    		                                        -266,600,000             -266,600,000   
      total operating expenses
    		                                        12,245,200,000             12,245,200,000   
      operating income from continuing operations
    		                                        3,244,800,000             3,244,800,000   
      interest income
    		                                        6,400,000             6,400,000   
      interest expense
    		                                        -482,600,000             -482,600,000   
      other income
    		                                        -23,200,000             -23,200,000   
      total other expense
    		                                        -499,400,000             -499,400,000   
      income from continuing operations before income taxes and equity in earnings of equity method investees
    		                                        2,745,400,000             2,745,400,000   
      equity in earnings of equity method investees, net of taxes
    		                                        12,900,000             12,900,000   
      income from continuing operations, net of taxes
    		                                        2,327,400,000             2,327,400,000   
      gain from discontinued operations, net of taxes
    		                                                        
      net income
    		                                        2,327,400,000             2,327,400,000   
      yoy
    		                                                        
      qoq
    		                                                        
      net income margin %
    		0% 0% 0% NaN% 0% 0% 0% 0% NaN% 0% 0% 0% 0% 0% 0% 0% NaN% 0% 0% 0% 0% 0% 0% 0% NaN% 0% 0% 0% 0% 0% 0% 0% NaN% 0% 0% NaN% 0% 0% 0% 0% Infinity% 0% NaN% 0% 0% 0% 0% 0% 0% 0% 0% 0% NaN% Infinity% 0% 0% 
      earnings per ordinary share – basic
    		                                        2,550,000             2,550,000   
      earnings from continuing operations
    		                                        2,550,000             2,550,000   
      earnings from discontinued operations
    		                                                        
      earnings per ordinary share – diluted
    		                                        2,530,000             2,530,000   
      weighted-average number of shares:
    		                                                        
      basic
    		                                        913,000,000             913,000,000   
      diluted
    		                                        918,500,000             918,500,000   
      amortization and impairment losses on intangible assetsassociated with products
    		                                         -455.4               
      share of loss of investments accounted for usingthe equity method
    		                                         -24               
      fx rates
    		                                                  1,000      
      r&d expenses
    		                                                  -491,000      
      shire acquisition related costs
    		                                                        
      operating expenses
    		                                                        
      financial expenses
    		                                                  -87,000      
      impact from shire’s purchase accounting
    		                                                        
      amortization of intangibles assets
    		                                                  -439,000      
      other non-cash items
    		                                                        
      amortization of intangible assets
    		                                                  -99,000      
      impairment losses on intangible assets
    		                                                  -121,000      
      profit before income taxes
    		                                                  143,300      
      net profit for the year attributable to the owners of the company
    		                                                  114,900      
      total assets
    		                                                  4,346.8      
      total equity
    		                                                  1,949      
      share of profit of associates accounted for using the equity method
    		                                                   -43,627,000,000     
      consolidated statement of operations and other comprehensive income
    		                                                        
      other comprehensive income
    		                                                        
      items that will not be reclassified to profit or loss
    		                                                        
      changes in fair value of financial assets measured at fair value through other comprehensive income
    		                                                   6,000   -6,478  
      remeasurements of defined benefit plans
    		                                                   -11,665     
      items that may be reclassified subsequently to profit or loss
    		                                                        
      exchange differences on translation of foreign operations
    		                                                   34,639   3,203  
      net changes on revaluation of available-for-sale financial assets
    		                                                        
      cash flow hedges
    		                                                   -33,793   -15,666  
      hedging cost
    		                                                   -4,909   -1,796  
      share of other comprehensive income of investments accounted for using the equity method
    		                                                   -94   -107  
      other comprehensive income for the year, net of tax
    		                                                   -9,822     
      total comprehensive income for the year
    		                                                   99,192     
      earnings per ads – basic
    		                                                     7,650,000   
      earnings per ads – diluted
    		                                                     7,600,000   
      see accompanying notes to condensed interim consolidated financial statements. condensed interim consolidated statements of income and other comprehensive income
    		                                                        
      other comprehensive income:
    		                                                        
      items that will not be reclassified to profit or loss:
    		                                                        
      re-measurement gain on defined benefit plans
    		                                                      461  
      items to be reclassified subsequently to profit or loss:
    		                                                        
      other comprehensive income for the period, net of tax
    		                                                      -20,383  
      total comprehensive income for the period
    		                                                      143,970  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-10-30 2025-07-30 2024-03-31 2023-05-11 2023-03-31 2023-02-07 2023-02-02 2022-11-04 2022-10-27 2022-08-04 2022-07-28 2022-03-31 2022-02-10 2022-02-03 2021-11-05 2021-10-28 2021-08-06 2021-07-30 2021-05-11 2021-03-31 2021-02-12 2020-11-10 2020-10-29 2020-07-31 2020-06-24 2020-05-13 2020-03-31 2020-02-13 2020-02-04 2019-11-29 2019-11-12 2019-10-31 2019-08-09 2019-07-31 2019-05-14 2019-03-31 2019-02-15 2019-02-14 2019-02-01 2018-12-31 2018-03-31 2016-03-31 
                                                
        total assets
      		14,248.3 14,248.3 15,108,792,000,000 13,957,750,000,000 13,957,750,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000  12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,821,094,000,000 12,821,094,000,000 12,821,094,000,000 12,821,094,000,000 63,879,300,000 12,821,094,000,000 12,821,094,000,000 13,792,773,000,000 13,792,773,000,000 13,884,107,000,000 13,884,107,000,000 13,884,107,000,000 13,900,023,000,000 13,900,023,000,000 13,872,322,000,000 13,900,023,000,000 63,879,300,000 4,106,463,000,000 4,106,463,000,000 63,879,300,000 4,106,500,000 3,824,100,000 
        total liabilities
      		7,312.4 7,312.4 7,834,788,000,000 7,603,078,000,000 7,603,078,000,000 7,494,495,000,000 7,494,495,000,000 7,494,495,000,000 7,494,495,000,000 7,494,495,000,000 7,494,495,000,000 7,494,495,000,000 7,735,116,000,000 7,735,116,000,000 7,735,116,000,000 7,735,116,000,000 7,735,116,000,000 7,735,116,000,000 7,735,116,000,000 7,735,116,000,000 8,093,608,000,000 8,093,608,000,000 8,093,608,000,000 8,093,608,000,000 26,123,300,000 8,093,608,000,000 8,093,608,000,000 8,606,782,000,000 8,606,782,000,000 8,720,519,000,000 8,720,519,000,000 8,720,519,000,000 8,736,435,000,000 8,736,435,000,000 8,708,734,000,000 8,736,435,000,000 26,123,300,000 2,089,054,000,000 2,089,054,000,000 26,123,300,000 2,089,100,000 1,812,900,000 
        total equity
      		6,936 6,936 7,274,005,000,000 6,354,672,000,000 6,354,672,000,000 5,683,523,000,000 5,683,523,000,000 5,683,523,000,000 5,683,523,000,000 5,683,523,000,000 5,683,523,000,000 5,683,523,000,000 5,177,177,000,000 5,177,177,000,000 5,177,177,000,000 5,177,177,000,000 5,177,177,000,000 5,177,177,000,000 5,177,177,000,000 5,177,177,000,000 4,727,486,000,000 4,727,486,000,000 4,727,486,000,000 4,727,486,000,000 37,756,000,000 4,727,486,000,000 4,727,486,000,000 5,185,991,000,000 5,185,991,000,000 5,163,588,000,000 5,163,588,000,000 5,163,588,000,000 5,163,588,000,000 5,163,588,000,000 5,163,588,000,000  37,756,000,000 2,017,409,000,000 2,017,409,000,000 37,756,000,000 2,017,400,000 2,011,200,000 
        assets
      		                                          
        non-current assets:
      		                                          
        property, plant and equipment
      		  1,989,777,000,000 1,691,229,000,000 1,691,229,000,000 1,582,800,000,000 1,582,800,000,000 1,582,800,000,000 1,582,800,000,000 1,582,800,000,000 1,582,800,000,000  1,453,917,000,000 1,453,917,000,000 1,453,917,000,000 1,453,917,000,000 1,453,917,000,000 1,453,917,000,000 1,453,917,000,000 1,453,917,000,000 1,386,370,000,000 1,386,370,000,000 1,386,370,000,000 1,386,370,000,000  1,386,370,000,000 1,386,370,000,000 1,331,931,000,000 1,331,931,000,000 1,331,932,000,000 1,331,932,000,000 1,331,932,000,000 1,326,775,000,000 1,326,775,000,000 1,316,531,000,000 1,326,775,000,000  536,801,000,000 536,801,000,000    
        goodwill
      		  5,410,067,000,000 4,790,723,000,000 4,790,723,000,000 4,407,749,000,000 4,407,749,000,000 4,407,749,000,000 4,407,749,000,000 4,407,749,000,000 4,407,749,000,000 4,407,749,000,000 4,033,917,000,000 4,033,917,000,000 4,033,917,000,000 4,033,917,000,000 4,033,917,000,000 4,033,917,000,000 4,033,917,000,000 4,033,917,000,000 4,012,528,000,000 4,012,528,000,000 4,012,528,000,000 4,012,528,000,000 19,006,200,000 4,012,528,000,000 4,012,528,000,000 4,240,251,000,000 4,240,251,000,000 4,187,006,000,000 4,187,006,000,000 4,187,006,000,000 4,170,390,000,000 4,170,390,000,000 4,161,403,000,000 4,170,390,000,000 19,006,200,000 1,029,248,000,000 1,029,248,000,000 19,006,200,000   
        intangible assets
      		  4,274,682,000,000 4,269,657,000,000 4,269,657,000,000 3,818,544,000,000 3,818,544,000,000 3,818,544,000,000 3,818,544,000,000 3,818,544,000,000 3,818,544,000,000 3,818,544,000,000 3,909,106,000,000 3,909,106,000,000 3,909,106,000,000 3,909,106,000,000 3,909,106,000,000 3,909,106,000,000 3,909,106,000,000 3,909,106,000,000 4,171,361,000,000 4,171,361,000,000 4,171,361,000,000 4,171,361,000,000 29,082,800,000 4,171,361,000,000 4,171,361,000,000 4,751,169,000,000 4,751,169,000,000 4,846,981,000,000 4,846,981,000,000 4,846,981,000,000 4,860,368,000,000 4,860,368,000,000 4,860,368,000,000 4,860,368,000,000 29,082,800,000 1,014,264,000,000 1,014,264,000,000 29,082,800,000   
        investments accounted for using the equity method
      		  89,831,000,000 99,174,000,000 99,174,000,000 96,579,000,000 96,579,000,000 96,579,000,000 96,579,000,000 96,579,000,000 96,579,000,000 96,579,000,000 112,468,000,000 112,468,000,000 112,468,000,000 112,468,000,000 112,468,000,000 112,468,000,000 112,468,000,000 112,468,000,000 107,334,000,000 107,334,000,000 107,334,000,000 107,334,000,000  107,334,000,000 107,334,000,000 108,185,000,000 108,185,000,000 114,658,000,000 114,658,000,000 114,658,000,000 114,658,000,000 114,658,000,000 114,658,000,000 114,658,000,000  107,949,000,000 107,949,000,000    
        other financial assets
      		  340,777,000,000 279,683,000,000 279,683,000,000 233,554,000,000 233,554,000,000 233,554,000,000 233,554,000,000 233,554,000,000 233,554,000,000 233,554,000,000 235,882,000,000 235,882,000,000 235,882,000,000 235,882,000,000 235,882,000,000 235,882,000,000 235,882,000,000 235,882,000,000 262,121,000,000 262,121,000,000 262,121,000,000 262,121,000,000  262,121,000,000 262,121,000,000 191,737,000,000 191,737,000,000 192,241,000,000 192,241,000,000 192,241,000,000 192,241,000,000 192,241,000,000 192,241,000,000 192,241,000,000  196,436,000,000 196,436,000,000    
        other non-current assets
      		  51,214,000,000 63,325,000,000 63,325,000,000 82,611,000,000 82,611,000,000 82,611,000,000 82,611,000,000 82,611,000,000 82,611,000,000 82,611,000,000 100,341,000,000 100,341,000,000 100,341,000,000 100,341,000,000 100,341,000,000 100,341,000,000 100,341,000,000 100,341,000,000 103,846,000,000 103,846,000,000 103,846,000,000 103,846,000,000 157,100,000 103,846,000,000 103,846,000,000 87,472,000,000 87,472,000,000 87,472,000,000 87,472,000,000 87,472,000,000 87,472,000,000 87,472,000,000 87,472,000,000 87,472,000,000 157,100,000 77,977,000,000 77,977,000,000 157,100,000   
        deferred tax assets
      		  393,865,000,000 366,003,000,000 366,003,000,000 362,539,000,000 362,539,000,000 362,539,000,000 362,539,000,000 362,539,000,000 362,539,000,000 362,539,000,000 353,769,000,000 353,769,000,000 353,769,000,000 353,769,000,000 353,769,000,000 353,769,000,000 353,769,000,000 353,769,000,000 308,102,000,000 308,102,000,000 308,102,000,000 308,102,000,000  308,102,000,000 308,102,000,000 88,991,000,000 88,991,000,000 88,991,000,000 88,991,000,000 88,991,000,000 88,991,000,000 88,991,000,000 88,991,000,000 88,991,000,000  64,980,000,000 64,980,000,000    
        total non-current assets
      		  12,550,212,000,000 11,559,794,000,000 11,559,794,000,000 10,584,376,000,000 10,584,376,000,000 10,584,376,000,000 10,584,376,000,000 10,584,376,000,000 10,584,376,000,000 10,584,376,000,000 10,199,400,000,000 10,199,400,000,000 10,199,400,000,000 10,199,400,000,000 10,199,400,000,000 10,199,400,000,000 10,199,400,000,000 10,199,400,000,000 10,351,662,000,000 10,351,662,000,000 10,351,662,000,000 10,351,662,000,000  10,351,662,000,000 10,351,662,000,000 10,799,736,000,000 10,799,736,000,000 10,849,281,000,000 10,849,281,000,000 10,849,281,000,000 10,840,895,000,000 10,840,895,000,000 10,821,664,000,000 10,840,895,000,000  3,027,655,000,000 3,027,655,000,000    
        current assets:
      		                                          
        inventories
      		  1,209,869,000,000 986,457,000,000 986,457,000,000 853,167,000,000 853,167,000,000 853,167,000,000 853,167,000,000 853,167,000,000 853,167,000,000 853,167,000,000 753,881,000,000 753,881,000,000 753,881,000,000 753,881,000,000 753,881,000,000 753,881,000,000 753,881,000,000 753,881,000,000 759,599,000,000 759,599,000,000 759,599,000,000 759,599,000,000 3,497,500,000 759,599,000,000 759,599,000,000 919,670,000,000 919,670,000,000 953,474,000,000 953,474,000,000 953,474,000,000 984,739,000,000 984,739,000,000 986,744,000,000 984,739,000,000 3,497,500,000 212,944,000,000 212,944,000,000 3,497,500,000   
        trade and other receivables
      		  668,403,000,000 649,429,000,000 649,429,000,000 696,644,000,000 696,644,000,000 696,644,000,000 696,644,000,000 696,644,000,000 696,644,000,000 696,644,000,000 783,091,000,000 783,091,000,000 783,091,000,000 783,091,000,000 783,091,000,000 783,091,000,000 783,091,000,000 783,091,000,000 757,005,000,000 757,005,000,000 757,005,000,000 757,005,000,000  757,005,000,000 757,005,000,000 741,907,000,000 741,907,000,000 741,907,000,000 741,907,000,000 741,907,000,000 741,907,000,000 741,907,000,000 741,907,000,000 741,907,000,000  420,247,000,000 420,247,000,000    
        income taxes receivable
      		  29,207,000,000 32,264,000,000 32,264,000,000 27,733,000,000 27,733,000,000 27,733,000,000 27,733,000,000 27,733,000,000 27,733,000,000 27,733,000,000 29,623,000,000 29,623,000,000 29,623,000,000 29,623,000,000 29,623,000,000 29,623,000,000 29,623,000,000 29,623,000,000 27,916,000,000 27,916,000,000 27,916,000,000 27,916,000,000  27,916,000,000 27,916,000,000       7,212,000,000         
        other current assets
      		  168,875,000,000 160,868,000,000 160,868,000,000 141,099,000,000 141,099,000,000 141,099,000,000 141,099,000,000 141,099,000,000 141,099,000,000 141,099,000,000 122,789,000,000 122,789,000,000 122,789,000,000 122,789,000,000 122,789,000,000 122,789,000,000 122,789,000,000 122,789,000,000 114,196,000,000 114,196,000,000 114,196,000,000 114,196,000,000 990,000,000 114,196,000,000 114,196,000,000 109,666,000,000 109,666,000,000 109,666,000,000 109,666,000,000 109,666,000,000 109,666,000,000 109,666,000,000 109,666,000,000 109,666,000,000 990,000,000 57,912,000,000 57,912,000,000 990,000,000   
        cash and cash equivalents
      		  457,800,000,000 533,530,000,000 533,530,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000 966,222,000,000 966,222,000,000 966,222,000,000 966,222,000,000 966,222,000,000 966,222,000,000 966,222,000,000 966,222,000,000 637,614,000,000 637,614,000,000 637,614,000,000 637,614,000,000 924,600,000 637,614,000,000 637,614,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 924,600,000 294,522,000,000 294,522,000,000 924,600,000   
        assets held for sale
      		  9,337,000,000 15,235,000,000 15,235,000,000        20,689,000,000 20,689,000,000 20,689,000,000 20,689,000,000 20,689,000,000 20,689,000,000 20,689,000,000 20,689,000,000 157,280,000,000 157,280,000,000 157,280,000,000 157,280,000,000  157,280,000,000 157,280,000,000 489,213,000,000 489,213,000,000 497,198,000,000 497,198,000,000 497,198,000,000 490,235,000,000 490,235,000,000 479,760,000,000 490,235,000,000  3,992,000,000 3,992,000,000    
        total current assets
      		  2,558,580,000,000 2,397,956,000,000 2,397,956,000,000 2,593,642,000,000 2,593,642,000,000 2,593,642,000,000 2,593,642,000,000 2,593,642,000,000 2,593,642,000,000 2,593,642,000,000 2,712,893,000,000 2,712,893,000,000 2,712,893,000,000 2,712,893,000,000 2,712,893,000,000 2,712,893,000,000 2,712,893,000,000 2,712,893,000,000 2,469,432,000,000 2,469,432,000,000 2,469,432,000,000 2,469,432,000,000 8,525,700,000 2,469,432,000,000 2,469,432,000,000 2,993,037,000,000 2,993,037,000,000 3,034,826,000,000 3,034,826,000,000 3,034,826,000,000 3,059,128,000,000 3,059,128,000,000 3,050,658,000,000 3,059,128,000,000 8,525,700,000 1,078,808,000,000 1,078,808,000,000 8,525,700,000   
        liabilities and equity
      		                                          
        liabilities
      		                                          
        non-current liabilities:
      		                                          
        bonds and loans
      		  4,476,501,000,000 4,042,741,000,000 4,042,741,000,000 4,141,418,000,000 4,141,418,000,000 4,141,418,000,000 4,141,418,000,000 4,141,418,000,000 4,141,418,000,000 203,993,000,000 4,613,218,000,000 4,613,218,000,000 4,613,218,000,000 4,613,218,000,000 4,613,218,000,000 4,613,218,000,000 4,613,218,000,000 4,613,218,000,000 4,506,487,000,000 4,506,487,000,000 4,506,487,000,000 4,506,487,000,000  4,506,487,000,000 4,506,487,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000 4,766,005,000,000  985,644,000,000 985,644,000,000    
        other financial liabilities
      		  687,833,000,000 534,269,000,000 534,269,000,000 468,943,000,000 468,943,000,000 468,943,000,000 468,943,000,000 468,943,000,000 468,943,000,000 468,943,000,000 517,677,000,000 517,677,000,000 517,677,000,000 517,677,000,000 517,677,000,000 517,677,000,000 517,677,000,000 517,677,000,000 399,129,000,000 399,129,000,000 399,129,000,000 399,129,000,000  399,129,000,000 399,129,000,000 240,215,000,000 240,215,000,000 235,786,000,000 235,786,000,000 235,786,000,000 235,786,000,000 235,786,000,000 235,786,000,000 235,786,000,000  91,223,000,000 91,223,000,000    
        net defined benefit liabilities
      		  143,882,000,000 127,594,000,000 127,594,000,000 145,847,000,000 145,847,000,000 145,847,000,000 145,847,000,000 145,847,000,000 145,847,000,000 145,847,000,000 158,857,000,000 158,857,000,000 158,857,000,000 158,857,000,000 158,857,000,000 158,857,000,000 158,857,000,000 158,857,000,000 156,617,000,000 156,617,000,000 156,617,000,000 156,617,000,000  156,617,000,000 156,617,000,000 156,513,000,000 156,513,000,000 156,513,000,000 156,513,000,000 156,513,000,000 156,513,000,000 156,513,000,000 156,513,000,000 156,513,000,000  87,611,000,000 87,611,000,000    
        income taxes payable
      		  4,381,000,000 24,558,000,000 24,558,000,000 21,634,000,000 21,634,000,000 21,634,000,000 21,634,000,000 21,634,000,000 21,634,000,000 21,634,000,000 33,690,000,000 33,690,000,000 33,690,000,000 33,690,000,000 33,690,000,000 33,690,000,000 33,690,000,000 33,690,000,000 54,932,000,000 54,932,000,000 54,932,000,000 54,932,000,000  54,932,000,000 54,932,000,000        61,900,000,000    67,694,000,000    
        provisions
      		  14,373,000,000 55,969,000,000 55,969,000,000 52,199,000,000 52,199,000,000 52,199,000,000 52,199,000,000 52,199,000,000 52,199,000,000 52,199,000,000 38,748,000,000 38,748,000,000 38,748,000,000 38,748,000,000 38,748,000,000 38,748,000,000 38,748,000,000 38,748,000,000 37,605,000,000 37,605,000,000 37,605,000,000 37,605,000,000  37,605,000,000 37,605,000,000 33,762,000,000 33,762,000,000 33,760,000,000 33,760,000,000 33,760,000,000 35,364,000,000 35,364,000,000 35,364,000,000 35,364,000,000  28,042,000,000 28,042,000,000    
        other non-current liabilities
      		  80,938,000,000 65,389,000,000 65,389,000,000 67,214,000,000 67,214,000,000 67,214,000,000 67,214,000,000 67,214,000,000 67,214,000,000 67,214,000,000 56,898,000,000 56,898,000,000 56,898,000,000 56,898,000,000 56,898,000,000 56,898,000,000 56,898,000,000 56,898,000,000 52,793,000,000 52,793,000,000 52,793,000,000 52,793,000,000 2,235,200,000 52,793,000,000 52,793,000,000 73,882,000,000 73,882,000,000 73,881,000,000 73,881,000,000 73,881,000,000 75,174,000,000 75,174,000,000 75,174,000,000 75,174,000,000 2,235,200,000 68,300,000,000 68,300,000,000 2,235,200,000   
        deferred tax liabilities
      		  113,777,000,000 270,620,000,000 270,620,000,000 451,511,000,000 451,511,000,000 451,511,000,000 451,511,000,000 451,511,000,000 451,511,000,000 451,511,000,000 542,852,000,000 542,852,000,000 542,852,000,000 542,852,000,000 542,852,000,000 542,852,000,000 542,852,000,000 542,852,000,000 710,147,000,000 710,147,000,000 710,147,000,000 710,147,000,000  710,147,000,000 710,147,000,000 721,456,000,000 721,456,000,000 869,313,000,000 869,313,000,000 869,313,000,000 875,813,000,000 875,813,000,000 867,061,000,000 875,813,000,000  90,725,000,000 90,725,000,000    
        total non-current liabilities
      		  5,521,684,000,000 5,121,138,000,000 5,121,138,000,000 5,348,764,000,000 5,348,764,000,000 5,348,764,000,000 5,348,764,000,000 5,348,764,000,000 5,348,764,000,000 5,348,764,000,000 5,961,940,000,000 5,961,940,000,000 5,961,940,000,000 5,961,940,000,000 5,961,940,000,000 5,961,940,000,000 5,961,940,000,000 5,961,940,000,000 5,917,710,000,000 5,917,710,000,000 5,917,710,000,000 5,917,710,000,000  5,917,710,000,000 5,917,710,000,000 6,053,733,000,000 6,053,733,000,000 6,197,158,000,000 6,197,158,000,000 6,197,158,000,000 6,206,555,000,000 6,206,555,000,000 6,197,803,000,000 6,206,555,000,000  1,351,545,000,000 1,351,545,000,000    
        current liabilities:
      		                                          
        trade and other payables
      		  547,521,000,000 649,233,000,000 649,233,000,000 516,297,000,000 516,297,000,000 516,297,000,000 516,297,000,000 516,297,000,000 516,297,000,000 516,297,000,000 343,838,000,000 343,838,000,000 343,838,000,000 343,838,000,000 343,838,000,000 343,838,000,000 343,838,000,000 343,838,000,000 318,816,000,000 318,816,000,000 318,816,000,000 318,816,000,000  318,816,000,000 318,816,000,000 327,394,000,000 327,394,000,000 327,394,000,000 327,394,000,000 327,394,000,000 327,394,000,000 327,394,000,000 327,394,000,000 327,394,000,000  240,259,000,000 240,259,000,000    
        other current liabilities
      		  619,174,000,000 566,689,000,000 566,689,000,000 584,949,000,000 584,949,000,000 584,949,000,000 584,949,000,000 584,949,000,000 584,949,000,000 584,949,000,000 542,651,000,000 542,651,000,000 542,651,000,000 542,651,000,000 542,651,000,000 542,651,000,000 542,651,000,000 542,651,000,000 499,386,000,000 499,386,000,000 499,386,000,000 499,386,000,000 349,700,000 499,386,000,000 499,386,000,000 439,055,000,000 439,055,000,000 439,076,000,000 439,076,000,000 439,076,000,000 437,888,000,000 437,888,000,000 437,888,000,000 437,888,000,000 349,700,000 263,930,000,000 263,930,000,000 349,700,000   
        liabilities held for sale
      		  1,410,000,000 144,000,000 144,000,000                87,190,000,000 87,190,000,000 87,190,000,000 87,190,000,000  87,190,000,000 87,190,000,000 215,034,000,000 215,034,000,000 216,775,000,000 216,775,000,000 216,775,000,000 220,094,000,000 220,094,000,000 201,145,000,000 220,094,000,000  3,214,000,000 3,214,000,000    
        total current liabilities
      		  2,313,103,000,000 2,481,940,000,000 2,481,940,000,000 2,145,730,000,000 2,145,730,000,000 2,145,730,000,000 2,145,730,000,000 2,145,730,000,000 2,145,730,000,000 2,145,730,000,000 1,773,176,000,000 1,773,176,000,000 1,773,176,000,000 1,773,176,000,000 1,773,176,000,000 1,773,176,000,000 1,773,176,000,000 1,773,176,000,000 2,175,898,000,000 2,175,898,000,000 2,175,898,000,000 2,175,898,000,000 8,487,100,000 2,175,898,000,000 2,175,898,000,000 2,553,049,000,000 2,553,049,000,000 2,523,361,000,000 2,523,361,000,000 2,523,361,000,000 2,529,880,000,000 2,529,880,000,000 2,510,931,000,000 2,529,880,000,000 8,487,100,000 737,509,000,000 737,509,000,000 8,487,100,000   
        equity
      		                                          
        share capital
      		  1,676,596,000,000 1,676,345,000,000 1,676,345,000,000 1,676,263,000,000 1,676,263,000,000 1,676,263,000,000 1,676,263,000,000 1,676,263,000,000 1,676,263,000,000 1,676,263,000,000 1,668,145,000,000 1,668,145,000,000 1,668,145,000,000 1,668,145,000,000 1,668,145,000,000 1,668,145,000,000 1,668,145,000,000 1,668,145,000,000 1,668,123,000,000 1,668,123,000,000 1,668,123,000,000 1,668,123,000,000  1,668,123,000,000 1,668,123,000,000 1,643,585,000,000 1,643,585,000,000 1,643,585,000,000 1,643,585,000,000 1,643,585,000,000 1,643,585,000,000 1,643,585,000,000 1,643,585,000,000   77,914,000,000 77,914,000,000  77,900,000  
        share premium
      		  1,747,414,000,000 1,728,830,000,000 1,728,830,000,000 1,708,873,000,000 1,708,873,000,000 1,708,873,000,000 1,708,873,000,000 1,708,873,000,000 1,708,873,000,000 1,708,873,000,000 1,688,424,000,000 1,688,424,000,000 1,688,424,000,000 1,688,424,000,000 1,688,424,000,000 1,688,424,000,000 1,688,424,000,000 1,688,424,000,000 1,680,287,000,000 1,680,287,000,000 1,680,287,000,000 1,680,287,000,000  1,680,287,000,000 1,680,287,000,000 1,650,232,000,000 1,650,232,000,000 1,650,232,000,000 1,650,232,000,000 1,650,232,000,000 1,650,232,000,000 1,650,232,000,000 1,650,232,000,000   90,740,000,000 90,740,000,000    
        treasury shares
      		  -51,259,000,000 -100,317,000,000 -100,317,000,000 -116,007,000,000 -116,007,000,000 -116,007,000,000 -116,007,000,000 -116,007,000,000 -116,007,000,000 -116,007,000,000 -59,552,000,000 -59,552,000,000 -59,552,000,000 -59,552,000,000 -59,552,000,000 -59,552,000,000 -59,552,000,000 -59,552,000,000 -87,463,000,000 -87,463,000,000 -87,463,000,000 -87,463,000,000  -87,463,000,000 -87,463,000,000 -57,142,000,000 -57,142,000,000 -57,142,000,000 -57,142,000,000 -57,142,000,000 -57,142,000,000 -57,142,000,000 -57,142,000,000   -74,373,000,000 -74,373,000,000    
        retained earnings
      		  1,391,203,000,000 1,541,146,000,000 1,541,146,000,000 1,479,716,000,000 1,479,716,000,000 1,479,716,000,000 1,479,716,000,000 1,479,716,000,000 1,479,716,000,000 1,479,716,000,000 1,509,906,000,000 1,509,906,000,000 1,509,906,000,000 1,509,906,000,000 1,509,906,000,000 1,509,906,000,000 1,509,906,000,000 1,509,906,000,000 1,369,972,000,000 1,369,972,000,000 1,369,972,000,000 1,369,972,000,000 12,022,600,000 1,369,972,000,000 1,369,972,000,000 1,595,431,000,000 1,595,431,000,000 1,569,365,000,000 1,569,365,000,000 1,569,365,000,000 1,569,365,000,000 1,569,365,000,000 1,569,365,000,000  12,022,600,000 1,557,307,000,000 1,557,307,000,000 12,022,600,000   
        other components of equity
      		  2,509,310,000,000 1,508,119,000,000 1,508,119,000,000 934,173,000,000 934,173,000,000 934,173,000,000 934,173,000,000 934,173,000,000 934,173,000,000 934,173,000,000 366,114,000,000 366,114,000,000 366,114,000,000 366,114,000,000 366,114,000,000 366,114,000,000 366,114,000,000 366,114,000,000 92,564,000,000 92,564,000,000 92,564,000,000 92,564,000,000  92,564,000,000 92,564,000,000 349,879,000,000 349,879,000,000 353,542,000,000 353,542,000,000 353,542,000,000 353,542,000,000 353,542,000,000 353,542,000,000   350,631,000,000 350,631,000,000    
        equity attributable to owners of the company
      		  7,273,264,000,000 6,354,122,000,000 6,354,122,000,000 5,683,019,000,000 5,683,019,000,000 5,683,019,000,000 5,683,019,000,000 5,683,019,000,000 5,683,019,000,000 5,683,019,000,000 5,173,037,000,000 5,173,037,000,000 5,173,037,000,000 5,173,037,000,000 5,173,037,000,000 5,173,037,000,000 5,173,037,000,000 5,173,037,000,000 4,723,483,000,000 4,723,483,000,000 4,723,483,000,000 4,723,483,000,000  4,723,483,000,000 4,723,483,000,000 5,181,985,000,000 5,181,985,000,000 5,159,582,000,000 5,159,582,000,000 5,159,582,000,000 5,159,582,000,000 5,159,582,000,000 5,159,582,000,000   1,997,424,000,000 1,997,424,000,000    
        non-controlling interests
      		  741,000,000 549,000,000 549,000,000 504,000,000 504,000,000 504,000,000 504,000,000 504,000,000 504,000,000 504,000,000 4,140,000,000 4,140,000,000 4,140,000,000 4,140,000,000 4,140,000,000 4,140,000,000 4,140,000,000 4,140,000,000 4,003,000,000 4,003,000,000 4,003,000,000 4,003,000,000  4,003,000,000 4,003,000,000 4,006,000,000 4,006,000,000 4,006,000,000 4,006,000,000 4,006,000,000 4,006,000,000 4,006,000,000 4,006,000,000   19,985,000,000 19,985,000,000    
        total liabilities and equity
      		  15,108,792,000,000 13,957,750,000,000 13,957,750,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000 13,178,018,000,000  12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,912,293,000,000 12,821,094,000,000 12,821,094,000,000 12,821,094,000,000 12,821,094,000,000 63,879,300,000 12,821,094,000,000 12,821,094,000,000 13,792,773,000,000 13,792,773,000,000 13,884,107,000,000 13,884,107,000,000 13,884,107,000,000 13,900,023,000,000 13,900,023,000,000 13,872,322,000,000  63,879,300,000 4,106,463,000,000 4,106,463,000,000 63,879,300,000   
        note
      		           2,022,000,000                               
        liabilities:
      		                                          
        equity:
      		                                          
        restricted cash
      		                        42,000,000            42,000,000   42,000,000   
        accounts receivable
      		                        3,071,600,000            3,071,600,000   3,071,600,000   
        investments
      		                        465,600,000            465,600,000   465,600,000   
        property, plant and equipment (pp&e)
      		                        6,506,900,000            6,506,900,000   6,506,900,000   
        deferred tax asset
      		                        135,000,000            135,000,000   135,000,000   
        accounts payable and accrued expenses
      		                        4,800,700,000            4,800,700,000   4,800,700,000   
        short term borrowings and capital leases
      		                        3,336,700,000            3,336,700,000   3,336,700,000   
        long term borrowings and capital leases
      		                        11,104,700,000            11,104,700,000   11,104,700,000   
        deferred tax liability
      		                        4,296,300,000            4,296,300,000   4,296,300,000   
        commitments and contingencies
      		                                          
        common stock of 5p par value; 1,500 shares authorized; and 925.5 shares issued and outstanding
      		                        82,200,000                  
        additional paid-in capital
      		                        25,567,400,000            25,567,400,000   25,567,400,000   
        treasury stock
      		                        -257,700,000            -257,700,000   -257,700,000   
        accumulated other comprehensive income
      		                        341,500,000            341,500,000   341,500,000   
        income tax receivables
      		                           7,212,000,000 7,212,000,000 7,212,000,000 7,212,000,000 7,212,000,000 7,212,000,000   7,212,000,000  8,545,000,000     
        accrued income taxes
      		                           61,900,000,000 61,900,000,000 61,900,000,000 61,900,000,000 61,900,000,000 61,900,000,000 61,900,000,000  61,900,000,000  67,694,000,000     
        non-current assets
      		                                          
        current assets
      		                                          
        non-current liabilities
      		                                          
        current liabilities
      		                                          
        income taxes recoverable
      		                                  7,212,000,000    8,545,000,000    
        other comprehensive income related to assets held for sale
      		                                     -4,795,000,000 -4,795,000,000    
        common stock of 5p par value; 1,500 million shares authorized; and 925.5 million shares issued and outstanding
      		                                    82,200,000   82,200,000   
        selected statements of operations data:
      		                                          
        revenue
      		                                          
        operating profit
      		                                        241,800,000 130,800,000 
        share of profit of investments accounted for using the equity method
      		                                        -32,200,000  
        profit before tax
      		                                        217,200,000 120,500,000 
        net profit for the year
      		                                        186,700,000 83,500,000 
        net profit attributable to owners of the company
      		                                        186,900,000 80,200,000 
        per share amounts
      		                                          
        basic earnings
      		                                          
        diluted earnings
      		                                        237,560,000  
        annual cash dividends
      		                                        180,000,000 180,000,000 
        cash dividends in u.s. dollars
      		                                        1,690,000 1,600,000 
        selected statements of financial position data:
      		                                          
        total bonds and loans
      		                                        985,700,000 768,200,000 
        other data:
      		                                          
        number of shares issued at end of period
      		                                        794,688,000,000  
        basic (losses) earnings
      		                                          
        diluted (losses) earnings
      		                                         101,710,000 
        number of shares outstanding at end of period
      		                                         790,284,000,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-10-30 2025-07-30 2023-02-07 2023-02-02 2022-11-04 2022-10-27 2022-08-04 2022-07-28 2022-02-10 2022-02-03 2021-11-05 2021-10-28 2021-08-06 2021-07-30 2021-02-12 2020-11-10 2020-10-29 2020-07-31 2020-02-13 2020-02-04 2019-11-12 2019-10-31 2019-08-09 2019-07-31 2019-02-15 
                                 
          cash flows from operating activities:
        		                         
          net profit for the period
        		112,550,000,000 124,279,000,000 285,903,000,000 285,903,000,000 166,753,000,000 166,753,000,000 105,021,000,000 105,021,000,000 241,541,000,000 241,541,000,000 183,721,000,000 183,721,000,000 137,726,000,000 200,421,000,000 179,027,000,000 86,589,000,000 86,589,000,000 82,519,000,000 42,728,000,000 42,728,000,000 33,280,000,000 33,280,000,000 -20,636,000,000 -20,636,000,000  
          depreciation and amortization
        		366,618,000,000 181,636,000,000 502,990,000,000 502,990,000,000 326,110,000,000 326,110,000,000 158,283,000,000 158,283,000,000 430,877,000,000 430,877,000,000 283,595,000,000 283,595,000,000 142,948,000,000 142,948,000,000 420,281,000,000 280,531,000,000 280,531,000,000 141,587,000,000 437,921,000,000 437,921,000,000 341,970,000,000 341,970,000,000 176,332,000,000 176,332,000,000 2,396,300,000 
          impairment losses
        		87,143,000,000 2,357,000,000 41,969,000,000 41,969,000,000 35,950,000,000 35,950,000,000 14,238,000,000 14,238,000,000 14,666,000,000 14,666,000,000 1,489,000,000 1,489,000,000 53,000,000 53,000,000 10,118,000,000 8,303,000,000 8,303,000,000 7,458,000,000 34,970,000,000 34,970,000,000 18,557,000,000 18,557,000,000 17,425,000,000 17,425,000,000  
          equity-settled share-based compensation
        		35,262,000,000 16,531,000,000 45,823,000,000 45,823,000,000 29,335,000,000 29,335,000,000 12,292,000,000 12,292,000,000 32,057,000,000 32,057,000,000 20,972,000,000 20,972,000,000 8,547,000,000 8,547,000,000 28,119,000,000 18,098,000,000 18,098,000,000 10,043,000,000 21,213,000,000 21,213,000,000 13,524,000,000 13,524,000,000 4,277,000,000 4,277,000,000  
          loss on sales and disposal of property, plant and equipment
        		916,000,000 584,000,000 -161,000,000 -161,000,000 145,000,000 145,000,000 7,000,000 7,000,000 258,000,000 258,000,000 219,000,000 219,000,000 94,000,000 94,000,000 -3,435,000,000 323,000,000 323,000,000 300,000,000 381,000,000 381,000,000 240,000,000 240,000,000 129,000,000 129,000,000  
          gain on divestment of business and subsidiaries
        		-17,929,000,000 -17,900,000,000 -959,000,000 -959,000,000 -640,000,000 -640,000,000 -320,000,000 -320,000,000 -1,095,000,000 -1,095,000,000 -730,000,000 -730,000,000 -365,000,000 -365,000,000 -38,273,000,000 -730,000,000 -730,000,000 -365,000,000 -12,964,000,000 -12,964,000,000 -3,516,000,000 -3,516,000,000 -2,837,000,000 -2,837,000,000  
          change in fair value of financial assets and liabilities associated with contingent consideration arrangements
        		989,000,000 764,000,000 4,323,000,000 4,323,000,000 446,000,000 446,000,000 136,000,000 136,000,000 -9,683,000,000 -9,683,000,000 -8,099,000,000 -8,099,000,000 -934,000,000 -934,000,000 8,888,000,000 19,937,000,000 19,937,000,000 19,297,000,000        
          finance (income) and expenses
        		72,142,000,000 33,400,000,000 71,635,000,000 71,635,000,000 33,565,000,000 33,565,000,000 -5,456,000,000 -5,456,000,000 100,589,000,000 100,589,000,000 58,028,000,000 58,028,000,000 25,216,000,000 25,216,000,000 115,359,000,000 81,092,000,000 81,092,000,000 27,235,000,000        
          share of loss of investments accounted for using the equity method
        		2,615,000,000 536,000,000 3,133,000,000 3,133,000,000 1,366,000,000 1,366,000,000 497,000,000 497,000,000 5,255,000,000 5,255,000,000 3,525,000,000 3,525,000,000 357,000,000 357,000,000 8,013,000,000    15,098,000,000 15,098,000,000      
          income tax expenses
        		66,254,000,000 26,351,000,000 41,273,000,000 41,273,000,000 53,269,000,000 53,269,000,000 50,452,000,000 50,452,000,000 115,077,000,000 115,077,000,000 100,704,000,000 100,704,000,000 85,252,000,000 22,558,000,000 56,330,000,000 38,972,000,000 38,972,000,000 47,772,000,000 13,280,000,000 13,280,000,000 -60,837,000,000 -60,837,000,000 -4,550,000,000 -4,550,000,000  
          changes in assets and liabilities:
        		                         
          decrease in trade and other receivables
        		38,286,000,000 48,083,000,000 6,856,000,000 6,856,000,000     82,243,000,000 82,243,000,000                
          increase in inventories
        		-42,031,000,000 -13,069,000,000 -34,240,000,000 -34,240,000,000 -15,778,000,000 -15,778,000,000 -9,118,000,000 -9,118,000,000     -21,009,000,000 -21,009,000,000            
          decrease in trade and other payables
        		-11,242,000,000 -27,780,000,000 -144,971,000,000 -144,971,000,000 -137,260,000,000 -137,260,000,000 -97,123,000,000 -97,123,000,000 -1,797,000,000 -1,797,000,000 -9,043,000,000 -9,043,000,000 -24,854,000,000 -24,854,000,000 -5,082,000,000 -26,336,000,000 -26,336,000,000 -23,153,000,000   -41,477,000,000 -41,477,000,000 -30,296,000,000 -30,296,000,000  
          increase in provisions
        		8,533,000,000 -23,404,000,000 11,605,000,000 11,605,000,000     -70,098,000,000 -70,098,000,000 -63,512,000,000 -63,512,000,000 -65,217,000,000 -65,217,000,000 66,844,000,000 41,490,000,000 41,490,000,000 2,177,000,000 40,055,000,000 40,055,000,000 47,591,000,000 47,591,000,000 9,149,000,000 9,149,000,000  
          decrease in other financial liabilities
        		-5,309,000,000  -7,906,000,000 -7,906,000,000   -44,152,000,000 -44,152,000,000                  
          other
        		-34,790,000,000 -86,420,000,000 21,258,000,000 21,258,000,000 -11,887,000,000 -11,887,000,000 -41,583,000,000 -41,583,000,000 -858,000,000 -858,000,000 -17,856,000,000 -17,856,000,000 -35,236,000,000 -35,236,000,000 14,129,000,000 -26,377,000,000 -26,377,000,000 -36,894,000,000 16,478,000,000 16,478,000,000 -15,575,000,000 -15,575,000,000 -13,535,000,000 -13,535,000,000 -37,800,000 
          cash generated from operations
        		680,006,000,000 248,418,000,000 848,529,000,000 848,529,000,000 414,451,000,000 414,451,000,000 105,097,000,000 105,097,000,000 848,607,000,000 848,607,000,000 473,883,000,000 473,883,000,000 202,760,000,000 202,760,000,000 756,290,000,000 472,116,000,000 472,116,000,000 197,344,000,000 687,508,000,000 687,508,000,000 431,671,000,000 431,671,000,000 180,470,000,000 180,470,000,000  
          income taxes paid
        		-91,891,000,000 -36,653,000,000 -173,363,000,000 -173,363,000,000 -115,432,000,000 -115,432,000,000 -24,945,000,000 -24,945,000,000 -107,224,000,000 -107,224,000,000 -78,707,000,000 -78,707,000,000 -35,902,000,000 -35,902,000,000 -174,694,000,000 -103,775,000,000 -103,775,000,000 -51,483,000,000 -210,267,000,000 -210,267,000,000 -97,656,000,000 -97,656,000,000 -59,894,000,000 -59,894,000,000  
          tax refunds and interest on tax refunds received
        		5,535,000,000 3,658,000,000 8,297,000,000 8,297,000,000 6,215,000,000 6,215,000,000 4,090,000,000 4,090,000,000 6,138,000,000 6,138,000,000 4,835,000,000 4,835,000,000   28,375,000,000 23,670,000,000 23,670,000,000  7,074,000,000 7,074,000,000 7,072,000,000 7,072,000,000 213,000,000 213,000,000  
          net cash from operating activities
        		593,651,000,000 215,423,000,000 683,463,000,000 683,463,000,000 305,234,000,000 305,234,000,000 84,241,000,000 84,241,000,000 747,521,000,000 747,521,000,000 400,011,000,000 400,011,000,000 166,858,000,000 166,858,000,000 609,971,000,000 392,011,000,000 392,011,000,000 145,861,000,000 484,315,000,000 484,315,000,000 341,087,000,000 341,087,000,000 120,789,000,000 120,789,000,000 4,610,100,000 
          capital expenditures
        		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
          free cash flows
        		593,651,000,000 215,423,000,000 683,463,000,000 683,463,000,000 305,234,000,000 305,234,000,000 84,241,000,000 84,241,000,000 747,521,000,000 747,521,000,000 400,011,000,000 400,011,000,000 166,858,000,000 166,858,000,000 609,971,000,000 392,011,000,000 392,011,000,000 145,861,000,000 484,315,000,000 484,315,000,000 341,087,000,000 341,087,000,000 120,789,000,000 120,789,000,000 4,610,100,000 
          cash flows from investing activities:
        		                         
          interest received
        		7,726,000,000 4,850,000,000 2,792,000,000 2,792,000,000 1,456,000,000 1,456,000,000 470,000,000 470,000,000 2,468,000,000 2,468,000,000 2,126,000,000 2,126,000,000 349,000,000 349,000,000 752,000,000 577,000,000 577,000,000 308,000,000 9,547,000,000 9,547,000,000 7,116,000,000 7,116,000,000 1,574,000,000 1,574,000,000  
          dividends received
        		584,000,000 250,000,000 3,234,000,000 3,234,000,000 2,415,000,000 2,415,000,000 138,000,000 138,000,000 2,598,000,000 2,598,000,000 142,000,000 142,000,000 139,000,000 139,000,000 215,000,000 177,000,000 177,000,000 177,000,000 1,382,000,000 1,382,000,000 1,141,000,000 1,141,000,000 1,169,000,000 1,169,000,000  
          acquisition of property, plant and equipment
        		-88,008,000,000 -47,913,000,000 -104,888,000,000 -104,888,000,000 -71,423,000,000 -71,423,000,000 -42,125,000,000 -42,125,000,000 -87,673,000,000 -87,673,000,000 -60,601,000,000 -60,601,000,000 -29,838,000,000 -29,838,000,000 -75,041,000,000 -50,479,000,000 -50,479,000,000 -23,135,000,000 -89,845,000,000 -89,845,000,000 -55,083,000,000 -55,083,000,000 -29,859,000,000 -29,859,000,000  
          proceeds from sales of property, plant and equipment
        		6,385,000,000 6,385,000,000 80,000,000 80,000,000 97,000,000 97,000,000 34,000,000 34,000,000 412,000,000 412,000,000 389,000,000 389,000,000 79,000,000 79,000,000 42,818,000,000 38,535,000,000 38,535,000,000 26,000,000 257,000,000 257,000,000 69,000,000 69,000,000 118,000,000 118,000,000  
          acquisition of intangible assets
        		-39,885,000,000 -27,155,000,000 -84,721,000,000 -84,721,000,000 -67,562,000,000 -67,562,000,000 -56,251,000,000 -56,251,000,000 -46,541,000,000 -46,541,000,000 -25,182,000,000 -25,182,000,000 -12,454,000,000 -12,454,000,000 -49,469,000,000 -30,413,000,000 -30,413,000,000 -17,342,000,000 -64,982,000,000 -64,982,000,000 -21,354,000,000 -21,354,000,000 -13,122,000,000 -13,122,000,000  
          acquisition of option to license
        		                         
          acquisition of investments
        		-229,000,000 -215,000,000 -5,441,000,000 -5,441,000,000 -4,694,000,000 -4,694,000,000 -2,933,000,000 -2,933,000,000 -7,600,000,000 -7,600,000,000 -3,591,000,000 -3,591,000,000 -3,251,000,000 -3,251,000,000 -9,479,000,000 -6,219,000,000 -6,219,000,000 -3,517,000,000 -7,327,000,000 -7,327,000,000 -3,946,000,000 -3,946,000,000 -3,133,000,000 -3,133,000,000  
          proceeds from sales and redemption of investments
        		4,010,000,000 1,128,000,000 20,553,000,000 20,553,000,000 18,400,000,000 18,400,000,000 6,178,000,000 6,178,000,000 16,065,000,000 16,065,000,000 10,070,000,000 10,070,000,000 483,000,000 483,000,000 73,717,000,000 50,650,000,000 50,650,000,000 44,437,000,000 47,795,000,000 47,795,000,000 40,582,000,000 40,582,000,000 14,458,000,000 14,458,000,000  
          acquisition of shares in associates
        		-623,000,000                         
          proceeds from sales of shares in associates
        		686,000,000                         
          proceeds from sales of business, net of cash and cash equivalents divested
        		29,645,000,000 29,291,000,000       2,138,000,000 2,138,000,000 2,138,000,000 2,138,000,000 2,138,000,000 2,138,000,000 124,969,000,000 31,400,000,000 31,400,000,000  375,536,000,000 375,536,000,000 375,536,000,000 375,536,000,000    
          payments for the settlement of forward exchange contracts designated as net investment hedges
        		-1,536,000,000                         
          net cash from investing activities
        		-81,326,000,000 -33,193,000,000 -168,610,000,000 -168,610,000,000 -121,920,000,000 -121,920,000,000 -94,714,000,000 -94,714,000,000 -172,487,000,000 -172,487,000,000 -103,349,000,000 -103,349,000,000 -70,445,000,000 -70,445,000,000 100,199,000,000 28,224,000,000 28,224,000,000 662,000,000 255,874,000,000 255,874,000,000 330,414,000,000 330,414,000,000 -41,603,000,000 -41,603,000,000 1,454,200,000 
          cash flows from financing activities:
        		                         
          net decrease in short-term loans and commercial papers
        		-341,780,000,000 -46,032,000,000             -84,997,000,000 -89,917,000,000 -89,917,000,000 -10,000,000,000        
          proceeds from issuance of bonds and long-term loans
        		526,060,000,000 183,555,000,000       249,334,000,000 249,334,000,000     1,179,515,000,000 1,179,515,000,000 1,179,515,000,000  496,190,000,000 496,190,000,000 496,190,000,000 496,190,000,000 496,190,000,000 496,190,000,000  
          repayments of bonds and long-term loans
        		-125,385,000,000 -125,296,000,000 -281,585,000,000 -281,585,000,000 -26,900,000,000 -26,900,000,000 -26,804,000,000 -26,804,000,000 -635,047,000,000 -635,047,000,000 -441,072,000,000 -441,072,000,000 -242,919,000,000 -242,919,000,000 -1,389,102,000,000 -1,265,629,000,000 -1,265,629,000,000 -9,979,000,000        
          proceeds from the settlement of cross currency interest rate swaps related to bonds and loans
        		                         
          acquisition of treasury shares
        		-51,603,000,000 -51,603,000,000 -26,929,000,000 -26,929,000,000 -26,929,000,000 -26,929,000,000 -26,929,000,000 -26,929,000,000 -52,538,000,000 -52,538,000,000 -2,542,000,000 -2,542,000,000 -2,542,000,000 -2,542,000,000 -2,138,000,000 -2,135,000,000 -2,135,000,000 -2,132,000,000        
          interest paid
        		-52,296,000,000 -16,692,000,000 -86,563,000,000 -86,563,000,000 -52,719,000,000 -52,719,000,000 -22,770,000,000 -22,770,000,000 -84,917,000,000 -84,917,000,000 -52,668,000,000 -52,668,000,000 -23,218,000,000 -23,218,000,000 -84,185,000,000 -47,562,000,000 -47,562,000,000 -30,207,000,000 -105,161,000,000 -105,161,000,000 -61,039,000,000 -61,039,000,000 -31,176,000,000 -31,176,000,000  
          dividends paid
        		-154,082,000,000 -145,295,000,000 -268,997,000,000 -268,997,000,000 -140,007,000,000 -140,007,000,000 -128,873,000,000 -128,873,000,000 -273,024,000,000 -273,024,000,000 -141,573,000,000 -141,573,000,000 -132,032,000,000 -132,032,000,000 -274,679,000,000 -141,754,000,000 -141,754,000,000 -133,115,000,000 -274,258,000,000 -274,258,000,000 -140,811,000,000 -140,811,000,000 -132,749,000,000 -132,749,000,000  
          repayments of lease liabilities
        		-22,318,000,000 -12,205,000,000 -32,510,000,000 -32,510,000,000 -20,996,000,000 -20,996,000,000 -10,325,000,000 -10,325,000,000 -29,904,000,000 -29,904,000,000 -20,536,000,000 -20,536,000,000 -10,328,000,000 -10,328,000,000 -27,710,000,000 -15,779,000,000 -15,779,000,000 -7,213,000,000        
          net cash from financing activities
        		-226,881,000,000 -214,900,000,000 -702,548,000,000 -702,548,000,000 -267,593,000,000 -267,593,000,000 -215,717,000,000 -215,717,000,000 -826,465,000,000 -826,465,000,000 -658,405,000,000 -658,405,000,000 -411,038,000,000 -411,038,000,000 -718,282,000,000 -418,210,000,000 -418,210,000,000 -192,765,000,000 -861,282,000,000 -861,282,000,000 -811,670,000,000 -811,670,000,000 -177,700,000,000 -177,700,000,000 -5,596,200,000 
          net increase in cash and cash equivalents
        		285,444,000,000 -32,670,000,000         -361,743,000,000 -361,743,000,000    2,025,000,000 2,025,000,000  -121,093,000,000 -121,093,000,000 -140,169,000,000 -140,169,000,000    
          cash and cash equivalents at the beginning of the year
        		385,113,000,000 385,113,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000 849,695,000,000       637,614,000,000 637,614,000,000 637,614,000,000 637,614,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000 702,093,000,000  
          effects of exchange rate changes on cash and cash equivalents
        		10,929,000,000 -2,435,000,000 23,141,000,000 23,141,000,000 32,720,000,000 32,720,000,000 22,485,000,000 22,485,000,000 9,549,000,000 9,549,000,000 3,402,000,000 3,402,000,000 3,324,000,000 3,324,000,000 -11,797,000,000 -8,570,000,000 -8,570,000,000 -1,585,000,000 -13,350,000,000 -13,350,000,000 -19,036,000,000 -19,036,000,000 -10,463,000,000 -10,463,000,000  
          cash and cash equivalents at the end of the period
        		681,486,000,000 350,008,000,000 685,141,000,000 685,141,000,000 798,137,000,000 798,137,000,000 645,991,000,000 645,991,000,000 724,341,000,000 724,341,000,000 607,881,000,000 607,881,000,000   617,705,000,000 631,069,000,000 631,069,000,000 589,787,000,000 568,279,000,000 568,279,000,000 543,517,000,000 543,517,000,000 593,745,000,000 593,745,000,000  
          decrease (increase) in trade and other receivables
        		                         
          notes
        		  2,022,000,000  2,022,000,000  2,022,000,000  2,021,000,000  2,021,000,000    2,020,000,000 2,020,000,000          
          increase in other financial liabilities
        		 -17,531,000,000   -48,068,000,000 -48,068,000,000   -51,158,000,000 -51,158,000,000 1,023,000,000 1,023,000,000 -7,985,000,000 -7,985,000,000            
          cash and cash equivalents reclassified to assets held for sale
        		              -70,000,000 -201,000,000 -201,000,000         
          net profit for the year
        		                         
          share of loss (profit) of investments accounted for using the equity method
        		               8,935,000,000 8,935,000,000 9,759,000,000        
          net increase in short-term loans and commercial papers
        		            1,000,000 1,000,000            
          net decrease in cash and cash equivalents
        		  -187,695,000,000 -187,695,000,000 -84,278,000,000 -84,278,000,000 -226,190,000,000 -226,190,000,000 -251,430,000,000 -251,430,000,000   -314,625,000,000 -314,625,000,000 -8,112,000,000   -46,242,000,000     -98,514,000,000 -98,514,000,000  
          cash and cash equivalents at the end of the year
        		                         
          increase in trade and other receivables
        		    -5,915,000,000 -5,915,000,000 -17,970,000,000 -17,970,000,000   -55,190,000,000 -55,190,000,000 -41,835,000,000 -41,835,000,000 -49,908,000,000 -1,542,000,000 -1,542,000,000 -25,845,000,000 -68,919,000,000 -68,919,000,000 -53,938,000,000 -53,938,000,000 -44,885,000,000 -44,885,000,000  
          increase in trade and other payables
        		                  -39,195,000,000 -39,195,000,000      
          proceeds from the settlement of cross currency interest rate swaps related to bonds
        		                         
          gain on sales and disposal of property, plant and equipment
        		                         
          decrease in provisions
        		    -12,939,000,000 -12,939,000,000 -20,106,000,000 -20,106,000,000                  
          acquisition of businesses, net of cash and cash equivalents acquired
        		        -49,672,000,000 -49,672,000,000 -27,549,000,000 -27,549,000,000 -27,549,000,000 -27,549,000,000     -4,590,000,000 -4,590,000,000 -4,580,000,000 -4,580,000,000 -4,650,000,000 -4,650,000,000  
          change in estimate of liabilities related to shp647
        		              -60,179,000,000 -60,179,000,000 -60,179,000,000 -60,179,000,000        
          decrease (increase) in inventories
        		                         
          payments for settlement of forward rate agreement related to bonds
        		              -34,830,000,000 -34,830,000,000 -34,830,000,000         
          loss on liquidation of foreign operations
        		                  399,000,000 399,000,000 399,000,000 399,000,000    
          decrease in inventories
        		        -39,268,000,000 -39,268,000,000 -24,965,000,000 -24,965,000,000   6,059,000,000 3,010,000,000 3,010,000,000 -4,367,000,000 92,741,000,000 92,741,000,000 70,981,000,000 70,981,000,000 52,642,000,000 52,642,000,000  
          acquisition of non-controlling interests
        		                  -1,700,000,000 -1,700,000,000 -1,700,000,000 -1,700,000,000 -1,700,000,000 -1,700,000,000  
          18
        		                         
          cash and cash equivalents reclassified back from assets held for sale
        		                  629,000,000 629,000,000 629,000,000 629,000,000 629,000,000 629,000,000  
          income tax benefit
        		                         
          gain on liquidation of foreign operations
        		                         
          proceeds from withdrawal of restricted deposits
        		                         
          facility fees paid for loan agreements
        		                         
          net income
        		                        2,327,400,000 
          adjustments to reconcile net income to net cash from operating activities:
        		                         
          share based compensation
        		                        189,500,000 
          expense related to the unwind of inventory fair value adjustments
        		                        42,800,000 
          change in deferred taxes
        		                        -246,000,000 
          change in fair value of contingent consideration
        		                       2,203,000,000 41,500,000 
          impairment of pp&e and intangible assets
        		                        205,500,000 
          gain on sale of oncology franchise
        		                        -266,600,000 
          changes in operating assets and liabilities:
        		                         
          increase in accounts receivable
        		                        -281,500,000 
          increase in sales deduction accrual
        		                        383,600,000 
          increase in inventory
        		                        -355,900,000 
          decrease in prepayments and other assets
        		                        -36,400,000 
          increase in accounts payable and other liabilities
        		                        247,700,000 
          proceeds from sale of oncology franchise
        		                        2,412,200,000 
          purchases of pp&e
        		                        -787,000,000 
          acquisition of business, net of cash acquired
        		                        -104,700,000 
          proceeds from sale of investments
        		                        31,800,000 
          proceeds from revolving line of credit, long term and short term borrowings
        		                        4,398,900,000 
          repayment of revolving line of credit, long term and short term borrowings
        		                        -9,551,700,000 
          payment of contingent consideration
        		                        -396,000,000 
          payment of dividend
        		                        -327,500,000 
          proceeds from issuance of stock for share-based compensation arrangements
        		                        306,800,000 
          effect of foreign exchange rate changes on cash and cash equivalents
        		                        -13,300,000 
          net increase in cash, cash equivalents, and restricted cash
        		                        454,800,000 
          cash, cash equivalents, and restricted cash at beginning of period
        		                        511,800,000 
          cash, cash equivalents, and restricted cash at end of period
        		                        966,600,000 
          supplemental information:
        		                         
          cash, cash equivalents, and restricted cash information:
        		                         
          cash and cash equivalents
        		                         
          restricted cash
        		                         
          change in fair value of contingent consideration liabilities
        		                  1,884,000,000 1,884,000,000 2,605,000,000 2,605,000,000 2,203,000,000   
          finance income and expenses
        		                  91,438,000,000 91,438,000,000 81,898,000,000 81,898,000,000  37,396,000,000  
          acquisition of business, net of cash and cash equivalents acquired
        		                         
          net increase in short-term loans
        		                         
          proceeds from issuarance of bonds and long-term loans
        		                         
          repayment of lease liabilities
        		                  -21,099,000,000 -21,099,000,000 -14,624,000,000 -14,624,000,000 -7,466,000,000 -7,466,000,000  
          payments into restricted deposits
        		                         
          net decrease in short-term loans
        		                  -325,242,000,000 -325,242,000,000 -461,371,000,000 -461,371,000,000 -500,164,000,000 -500,164,000,000  
          repayment of bonds and long-term loans
        		                  -623,149,000,000 -623,149,000,000 -623,119,000,000 -623,119,000,000    
          purchase of treasury shares
        		                  -3,725,000,000 -3,725,000,000 -3,724,000,000 -3,724,000,000 -3,000,000 -3,000,000  
          share of profit of investments accounted for using the equity method
        		                    -4,031,000,000 -4,031,000,000 -2,344,000,000 -2,344,000,000  
          finance expenses
        		                      37,396,000,000   
          231,480
        		                      593,745,000,000   
          finance incomes
        		                         
          share of loss of associates accounted for using the equity method
        		                         
          payments into time deposits
        		                         
          proceeds from withdrawal of time deposits
        		                         
          proceeds from bonds and long-term loans
        		                         
          repayments of obligations under finance lease
        		                         
          (reversal of) impairment losses
        		                         
          gain on divestment of business
        		                         
          gain on sales of subsidiaries
        		                         
          share of gain of associates accounted for using the equity method
        		                         
          proceeds from sales of businesses, net of cash and cash equivalents divested
        		                         
          proceeds from long-term loans
        		                         
          proceeds from issuance of bonds
        		                         
          repayment of obligations under finance lease
        		                         
          product sales
        		                         
          total revenues
        		                         
          non gaap total revenues
        		                         
          operating income from continuing operations
        		                         
          non gaap operating income
        		                         
          net income margin
        		                         
          non gaap ebitda margin
        		                         
          non gaap net income
        		                         
          diluted earnings per ads
        		                         
          non gaap diluted earnings per ads
        		                         
          non gaap free cash flow
        		                         
          the non gaap financial measures included within this release are explained on pages 14 – 15, and are reconciled to the most directly comparable financial measures prepared in accordance with u.s. gaap on pages 11 – 13.
        		                         
          non gaap total revenues exclude the receipts of upfront license fees.
        		                         
          percentage point change (ppc).